Vadodara, India

Ganesh Sangaiah

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sun Pharma Advanced Research Company Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ganesh Sangaiah. Retrieved from https://idiyas.com/inventor/ganesh-sangaiah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ganesh Sangaiah: Innovator in Inhalation Devices

Introduction

Ganesh Sangaiah is a notable inventor based in Baroda, India. He has made significant contributions to the field of medical devices, particularly in the area of inhalation technology. His work focuses on improving the delivery of medication to patients through innovative devices.

Latest Patents

Ganesh Sangaiah holds a patent for an inhalation-activatable device designed for the administration of medicament in powder form to the respiratory system of a patient. This invention aims to enhance the efficiency and effectiveness of drug delivery, ensuring that patients receive the necessary treatment in a user-friendly manner. He has 1 patent to his name.

Career Highlights

Ganesh is currently employed at Sun Pharma Advanced Research Company Limited, where he continues to develop and refine medical technologies. His role at the company allows him to collaborate with other experts in the field and contribute to advancements in pharmaceutical research.

Collaborations

Some of his coworkers include Subhas Balaram Bhowmick and Prashant Kane. Their collective expertise fosters a collaborative environment that drives innovation within the company.

Conclusion

Ganesh Sangaiah's work in inhalation devices exemplifies the impact of innovation in healthcare. His contributions are paving the way for more effective treatment options for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…